No Increased Risk of Posttransplant Lymphoproliferative Disorder Following Alemtuzumab Induction in Kidney Transplant.
- Resource Type
- Article
- Source
- Experimental & Clinical Transplantation; Jun2019, Vol. 17 Issue 3, p320-325, 6p
- Subject
- Language
- ISSN
- 13040855